ð¥è¿ã¥ã匷å¶ðæ¥çš®ð¥ã»ã»ã»ãã¡ãŠããã¢ãŠãâŒïžãã¡ãŠãçããªâŒïž ãã¡æã¡ðæ³šå° ïŒ ã¯ã¯ãã³æ³šå°ð ((((ïŒïŸÐïŸ)))))))
ã¢ã¡ãªã«ã®åäŸãçãããã¡æã¡ã®ð泚å°ãã®åç»ðèŠãŸããã以äžãæ°ã«ãªã£ãæãæåèµ·ããã®å·»ãâŠ_Ï(_ ðŠ
â ããã«ã¿æ ªãæ»
ãŒãæãç°¡åãªæ¹æ³ã¯CNNæŸéãæ¶ãããšããããŠå
±åå
ã«æ祚ããããšã§ããããŒã¬ã³ã»ããŒãã«ãäžé¢è°å¡ã
â¡ è£ãïŒãµãïŒïŒãæã
ã¯12æ³ãã18æ³ãžã®ã¯ã¯ãã³æ¥çš®ãåããããå§åãããç¶ããã€ããã§ããŸã ã¯ã¯ãã³æ¥çš®çãäœãå°å瀟äŒãšã®ååãç¶ããŠãããŸããããããæã
ãããããã®ãçªæéšéããå°å瀟äŒã«çºè¶³ããçç±ã®1ã€ã§ããååããŠã圌ããäœãå¿
èŠãšããŠããã®ããå€æããããã§ãããã»ã»ã»ã»ãçªæéšéãâïžâŒïžð§ðŠ
⢠6å7ç§ïŒâŠãããããã®ãé£ãã§äžçæžåœã«ã€ããŠæ¥ã ã ã«ããã»ã¬ã³ã®æ åã¯ð ðð§
⣠6å22ç§ïŒãã€ãã³ãä»ããããããã¯ã³ãã¥ããã£ãŒããã³ãã¥ããã£ãŒãžãè¿æããè¿æãžãšè¡ãå¿
èŠããããŸãããããŠãšãã«ã¯æåéããã¢ãäžè»äžè»ããã¯ããŠãæ®ãã®äººã
ãå©ããŠãããå¿
èŠããããŸãã(ã¯ã¯ãã³æ¥çš®ãå§ã)ãŠã£ã«ã¹ããä¿è·ãããããã«ãã
ðã¯ã¯ãã³æ¥çš®ãæåŠãããã©ã³ãæ¯æè
ã説åŸã§ããã®ã¯ããã©ã³ãå倧統é ã®ã¿ https://miu.ismedia.jp/r/c.do?1vVW_14YX_2L0_sds ãããããããã€ðŠ
†ã«ãã©ããªã¹ïŒãäœãæã£ãŠããªã人ãã¡ã¯ãæ®ãã®ãéã䜿ã£ãŠããŸãæåã§ããªãã®ãã¬ããã»ã»ã»ãäžåãªã«ãã©ã»ããªã¹ã®ç¬ããç¶ãã»ã»ã»
⥠ã«ãŒãªãŒå°å
ç
é¢ã»å°å
ææçå°éå»ãé©åãªæäžéãç¹å®ã§ããã°ã倧èŠæš¡ãªæ²»éšãé²ããããŸãããã»ã»ã»âïž((((ïŒïŸÐïŸ)))))))âïž äººäœæ²»éšâŠäººäœå®éš
⊠ã¹ã¿ã³ãã©ãŒã倧åŠã»ææçåŠææãå¿ççã¯2åç®ã®æ¥çš®åŸ2ã3æ¥ã§çºçã確èªãããŠããŸããèžã®çã¿ãåŒåžå°é£ãéåã§ããªããªã©ã®çç¶ãèŠãããŸããã
⧠8å37ç§ïŒãã¡æã¡ðãããã¯ç°¡åã«å
¥æã§ããããã¯ç¡æã§ããã«å©çšã§ããŸããã§ããããããªãã¯äžäœäœãåé¡ãªã®ïŒãšå°ããã¹ãã§ãããããä¹ãè¶ããªããããã®æ¿æ²»çãªçºèšãä¹ãè¶ããªããããããä¹ãè¶ããããšã§ãããããŠå®¶æã®äžã§èªåã®åœãæããªãããã
ãã¡ãŠããã¢ãŠãïŒãã¡ãŠãçããªïŒ ãã¡æã¡ð泚å°ãã¯ã¯ãã³æ³šå°ð
âš 8å52ç§ïŒïŒ£ïŒ°ïŒ¡ïŒ£ 2021ãä»æ¥ãç§ã¯ããã§æ¿åºã«èšããããããªãæ¹ã®æå©ãã¯ãããªããããªãæ¹ã®çŠç¥ã¯ãããªãããã¡ãŠãã®çã泚å°ãæã£ãŠå®¶ã®ãã¢ãããã¯ããªãã§ïŒé Œãããç§ãã¡ã«æ§ããªãã§ãâŒïžã
ïŒ æ¥æ¬ç  ã¿ãããªéãŸã J CPAC ãããã£ãšãã£ãšæåã«ãªã£ãŠçãäžããã°è¯ãã®ã«ãªãã ðð§ ïŒ
ãŒãŒãŒãŒãŒãŒãŒãŒãŒãŒãŒãŒãŒãŒãŒãŒãŒãŒãŒãŒãŒãŒãŒãŒãŒãŒãŒãŒãŒãŒãŒãŒãŒãŒãŒãŒãŒ
ã¢ã¡ãªã«ã®ä¿å®ã®æ¹ã ã«ããã C P A C ïŒïŒïŒïŒãã«æåŸ ããããšããããæ¥æ¬ããåå ã§ããã®ã¯ãè€äºå³åæ°ã ãã§ããããããâŒïž ç®éããäœããã§ãéã沢山䜿ã£ãŠã®åå ã ã£ãããã§ããã è€äºå³åããããããããããªããªé 匵ã£ãŠãã ãããŸãããð§ðŠ
ãŒãŒãŒãŒãŒãŒãŒãŒãŒãŒãŒãŒãŒãŒãŒãŒãŒãŒãŒãŒãŒãŒãŒãŒãŒãŒãŒãŒãŒãŒãŒãŒãŒãŒãŒãŒãŒ
äžèšã¯â¡Mari's Life in Americaâ¡ããã®ããã°ãã転èŒãããŠããã ããŸããããã£ã±ãçºè¡šãããŠãã人æ°ããããã£ãšå€ãã®æ¹ãã¯ã¯ãã³æ¥çš®åŸã«äº¡ããªã£ãŠããããã§ããæ¥æ¬ãããã ãšæããŸãã
ãããŠãç¹ã«ããã®éšåãæ°ã«ãªããŸãããð âŒïžãã»ã»ã»ããããããã²ã€ã財å£ã®äººå£åæžããã°ã©ã ã ãšãããããã®ä»®èª¬ã«ãŽã£ããåœãŠã¯ãŸããŸãã第äžæ³¢ã¯ãåŒåžåšç³»ã®ææçã§è人ã殺ãããšã第2ã®æ³¢ã¯ãçãæ®ã£ãè¥è ãã¿ãŒã²ããã«ããŠãäžåŠæè¡ãããããšã§ãã æ°ã¥ããŠã¿ããšãåœãã¢ã¡ãªã«ã§ã®ã¡ãã»ãŒãžã³ã°ã¯ãä»ã¯è人ã«ã¯èå³ããªããåäŸãã¿ãŒã²ããã§ããåäŸãã¡ã«çŠç¹ãåœãŠãŠããããããã»Â°Â°ã»(ïŒ_ïŒ)ã»Â°Â°ã»ã
ãããæ¬åœã«èšããŸããããã 人 å·¥ å æž èš ç» ã ((((ïŒïŸÐïŸ)))))))
ïŒ â¡Mari's Life in Americaâ¡ https://ameblo.jp/mari-love-usa ãããããäžéšæç²ãïŒ ã¿ãŒã²ããã¯åäŸãã¡ãžâŠãææªã®å Žåããã®ãããªäºãèæ ®ãã¹ãâŠïŒ ð§ðŠ ïŒ
ã»èåãªå»åž«ïŒCOVIDã¯ã¯ãã³ã¯ "泚å°ã«ãããã€ãªãã "ã§ãããç±³åœã§å°ãªããšã5äžäººã®æ»äº¡è ãåºããå¯èœæ§ãããã
ã»çŸåšå®éšäžã®COVID-19ã¯ã¯ãã³ãè¥è ãäžåŠã«ããããçãå©é·ãããããå¯èœæ§ããããç±³åœã§ã¯ãã§ã«5äžäººããïŒçŸåšïŒ7äžäººã®æ»è ãåºããŠããå¯èœæ§ããããšã®æžå¿µãè¡šæã
ã»ããããŠããã€ãªãã第1段éã®ããã°ã©ã å šäœã¯ã人ã ãææã«é¥ããŠéé¢ãããã€ãªããäœæŠã®ç¬¬2段éãšæãããã¯ã¯ãã³ãåãå ¥ããæºåãããããã®ãã®ã ã£ãã®ã§ããã
ã»âŠå éšåçºè ã®ååãåŸãŠãã¡ãã£ã±ã¢ã»ã¡ãã£ã±ã€ãã»ãµãŒãã¹ã»ã³ã¿ãŒïŒCMSïŒã®ããŒã¿ã掻çšããçµæãæ»äº¡çã¯æšæºçãªå ±åã®10å以äžã§ãããšèããŠããããšã匷調ããŸããã
ã»å éšåçºè ãæããã«ãã5äžäººã®å®éã®æ»äº¡è æ°ãã泚å°ã«ãããã€ãªããã®å®£äŒã
ã»ã2016幎ã®ããŒããŒã倧åŠã®ããŒã¿ãããã¯ã¯ãã³æ害äºè±¡å ±åã·ã¹ãã ïŒVAERSïŒã¯ãå®éã«èµ·ãã£ãŠããããšã®10ïŒ çšåºŠããå ±åããŠããªãããšãããã£ãŠããŸããã
ã»âŠã€ãŸãã10åã«ãªããšèããŠããŸããç§ãã¡ã¯5äžäººã®ã¢ã¡ãªã«äººãæ»ãã ãšèããŠããŸãã
ã»âŠå®éã®æ»äº¡è æ°ãäžèšã®å ±åæžã®10åã§ããã°ãç±³åœã§ã®å®éã®æ»äº¡è æ°ã¯7äžäººã«è¿ã¥ããŠããããšã«ãªããŸãã
ã»ããã®æ°ããå®éšçãªéºäŒåæ²»çã®æ³šå°ããè¥å¹Žå±€ã®ãããäžåŠçãå©é·ããå¯èœæ§ãå±æ§ããŠããŸãã p53ãBRCAïŒä¹³ããéºäŒåïŒãšçžäºäœçšãããšããã
æåã®æ³šå°ã§ããã£ãããšã«åºã¥ããŠãæçµçã«ããã«ã€ãªããã®ã§ã¯ãªãããšéåžžã«å¿é
ããŠããŸããçã«ãªãå¯èœæ§ãããã®ã§ããã
ã»ããã«ããæ¥æ¬äººã¯ãã§ã«ãè質ç²åãåµå·£ã«éäžããããšã瀺ããŠããŸãããšèª¬æããŠããŸããäžåŠçã«ãªãã®ã§ã¯ïŒ
ã»ããããããã²ã€ã財å£ã®äººå£åæžããã°ã©ã ã ãšãããããã®ä»®èª¬ã«ãŽã£ããåœãŠã¯ãŸããŸãã 第äžæ³¢ã¯ãåŒåžåšç³»ã®ææçã§è人ã殺ãããšã 第2ã®æ³¢ã¯ãçãæ®ã£ãè¥è
ãã¿ãŒã²ããã«ããŠãäžåŠæè¡ãããããšã§ãã æ°ã¥ããŠã¿ããšãåœãã¢ã¡ãªã«ã§ã®ã¡ãã»ãŒãžã³ã°ã¯ãä»ã¯è人ã«ã¯èå³ããªããåäŸãã¿ãŒã²ããã§ããåäŸãã¡ã«çŠç¹ãåœãŠãŠããã
èåãªå»åž«ãŒCOVIDã¯ã¯ãã³ã¯ "泚å°ã«ãããã€ãªãã "ã§ãããç±³åœã§å°ãªããšã5äžäººã®æ»äº¡è ãåºããå¯èœæ§ãããã
ç§ãã¡ã¯äžçèŠæš¡ã®ãã€ãªãããªãºã ã®é©çšãåããŠãããšä¿¡ããŠããŸãïŒãããŠããã¯äœå¹Žãåããèšç»ãããŠããããã§ããïŒ
2021幎7æ8æ¥ïŒã©ã€ããµã€ããã¥ãŒã¹ïŒ - ãã€ãã®åœéè£å€åŒè·å£«ãã©ã€ããŒã»ãã§ã«ããã·ã¥æ°ãšã®ççŽãªã€ã³ã¿ãã¥ãŒã®äžã§ãèåãªå»åž«ã§ããããŒã¿ãŒã»ããã«ããŒå士ã¯ã圌ãã泚å°ã«ãããããã¬ã³ãçãªãã€ãªããããšåŒãã ãã®ãæ¯ãè¿ããçŸåšå®éšäžã®COVID-19ã¯ã¯ãã³ãè¥è ãäžåŠã«ããããçãå©é·ãããããå¯èœæ§ããããç±³åœã§ã¯ãã§ã«5äžäººããïŒçŸåšïŒ7äžäººã®æ»è ãåºããŠããå¯èœæ§ããããšã®æžå¿µãè¡šæããŸããã
6æ11æ¥ã«è¡ãããã€ã³ã¿ãã¥ãŒã§ãå ç§å»ãå¿èç å»ã§ãããå»åŠææã2ã€ã®äž»èŠãªå»åŠéèªã®ç·šéè ã§ããããã«ãã¯ããç§ãã¡ã¯äžçèŠæš¡ã§ãäœå¹Žãåããèšç»ãããŠãããšæããããã€ãªããã®é©çšãåããŠãããšä¿¡ããŠããŸãããšæèšããŠããŸãã
ãã®ãã€ãªããã¯2段éã«åãããŠãããšèããŠããããã®ãã¡ã®ã第1段éãã¯ããäžçäžã«åºãã£ãåŒåžåšç³»ãŠã€ã«ã¹ã§ãå€ãã®äººå£ã®çŽ1ïŒ ãšããæ¯èŒçå°æ°ã®äººã ã«åœ±é¿ãäžãããã倧ããªææãçã¿åºããããšãããã®ã§ããã
ãã®ææå¿ã«ãããæ¿åºã¯ææ¥åæ¢ããã¹ã¯ççšçŸ©åã倧éãã¹ããªã©ãæ§ã ãªã¬ãã«ã®ç·©åæ¿çãå®æœããŸãããããã³ãããã¯ã«å¯Ÿããå ¬è¡è¡çäžã®å¯Ÿå¿ã§è¡ãããããããããšãããã³ãããã¯ãæªåãããã®ã§ãããšè¿°ã¹ãŠããŸãã
ãã®çµæã"å ¥é¢ãæ»äº¡ãçŽ85ïŒ æžå° "ããã«ããããããã"åæ¹é¢ããã®åçº "ãåããŸããã
ãç§ãã¡ãçºèŠããã®ã¯ãæ©ææ²»çã®æå¶ãã¯ã¯ãã³ã®éçºãšå¯æ¥ã«é¢ä¿ããŠãããšããããšã§ããããšãã«ãã¯èª¬æããŸãã
ããããŠããã€ãªãã第1段éã®ããã°ã©ã å šäœã¯ã人ã ãææã«é¥ããŠéé¢ãããã€ãªããäœæŠã®ç¬¬2段éãšæãããã¯ã¯ãã³ãåãå ¥ããæºåãããããã®ãã®ã ã£ãã®ã§ããã
圌ã¯ãã誰ãèåŸã«ããã®ãã¯ããããªãããšããªããããã圌ãã¯ããã¹ãŠã®äººéã«ã¡ãã»ã³ãžã£ãŒRNAãã¢ãããŠã€ã«ã¹ã®DNAãæ³šå ¥ããããã«ããã¹ãŠã®è ã«éãåºãããšããŠãããããšã¯æããã§ãããšåŒ·èª¿ããŠããŸãã
ãã®åé¡ã«å¯ŸåŠããããã«ããã«ãã¯ãç§ãã¡ã®ç®æšã¯ãã¯ã¯ãã³ãæ¥çš®ã§ããªã倧èŠæš¡ãªã°ã«ãŒãïŒäººã ïŒãéããããšã§ãããšèªããŸããã
ãã®ãããªã°ã«ãŒããšã¯ãCOVID-19ãããã§ã«å埩ãïŒäŸãã°ãããµã¹å·ã§ã¯å°ãªããšã80ïŒ ïŒãèªç¶å ç«ã享åããŠãã人ããåã«ãCOVID-å埩ã®çããã®ãã人ãé«ãå²åã§å«ãŸããã¯ãã§ãã
ãŸããå®éšçãªã¯ã¯ãã³ãé倧ãªè åšã§ããã«ãããããããCOVID-19ã®ãªã¹ã¯ãšã¯ç¡é¢ä¿ã§ããåäŸãã¡ããåŠåš äžã®å¥³æ§ãªã©ãå«ãŸããŸãã
ãç§ãã¡ã¯ã倧ããªæ°ã®äººã ãå¿ èŠã§ãããããã¹ãŠã®è ã«éãåºããšããïŒã¢ãžã§ã³ãïŒãæã¡ç Žãããšãã§ããã°ããã®çã®ç®çãæããã«ãªããšæããŸããã
ãŸããCOVID-19ã®å®éšçãªåäŸãžã®ã¯ã¯ãã³æ¥çš®ãäžæ¢ããããšã«ã€ããŠã¯ããçŸåšã800人ã®è¥è ãå¿ççïŒå¿èã®ççïŒãçºçããŠããŸããç§ã¯å¿èå°éå»ã§ãããèšåºçã«æš©åšã®ããç«å Žã«ãããŸãããè¥å¹Žå±€ã«ã¯ã¯ãã³ãæ¥çš®ããŠãèšåºçã«äœã®ã¡ãªããããªãããšããã1äŸã§ãå€ããããšæèŠããŸããããšè¿°ã¹ãŠããŸãã
ðCDCã®ãäžæ£è¡çºãã®çœª
çŸç 管çã»ã³ã¿ãŒïŒCDCïŒããã®ä»ã®æ©é¢ã¯ããããã®æ³šå°ã®ãªã¹ã¯ãæžããããã«ååãªæ³šæãæã£ãŠããªãããããã«ãã¯åœŒãã®è¡åãäžæ£è¡çºã§ãããšéé£ããŠããŸãã
ããã®ããã°ã©ã ã«ã¯ãã¯ãªãã£ã«ã«ã€ãã³ãå§å¡äŒãããŒã¿å®å šæ§ç£èŠå§å¡äŒã人éå«çå§å¡äŒãååšããŸããããããã®çµç¹ã¯ããã¹ãŠã®å€§èŠæš¡ãªèšåºç 究ã«å¿ é ã§ãã
ãã®ããã«ãä»åã®äºä»¶ã¯ãäžæ£è¡çºããšããèšèã§è¡šçŸãããŠããŸãããããã¯æš©åšããç«å Žã®äººéã«ããäžæ£è¡çºã§ããå®å šå¯ŸçãæœãããŠããªãç¶æ ã§ãäœãèµ·ãã£ãŠããã®ãã¯ãåããããã ãããšæããŸããã
ããã¯ããããåœã®æŽå²äžãæ倧ã®çœ¹æ£çãšæ»äº¡çã䌎ãçç©åŠç補åã®æ倧ã®é©çšãã§ãããšããããããŠ6æ11æ¥ããããµã¹A&Mã®å»åŠææã¯ãçŸåšã¢ã¡ãªã«ã§å ±åãããŠããæ»äº¡è æ°ã¯ "5,000人以äž"ãå ¥é¢è æ°ã¯ "15,000人 "ã§ãããšèª¬æããŸããã
ããããå éšåçºè ã®ååãåŸãŠãã¡ãã£ã±ã¢ã»ã¡ãã£ã±ã€ãã»ãµãŒãã¹ã»ã³ã¿ãŒïŒCMSïŒã®ããŒã¿ã掻çšããçµæãæ»äº¡çã¯æšæºçãªå ±åã®10å以äžã§ãããšèããŠããããšã匷調ããŸããã
ðå
éšåçºè
ãæããã«ãã5äžäººã®å®éã®æ»äº¡è
æ°ãã泚å°ã«ãããã€ãªããã®å®£äŒã
ãç§ãã¡ã¯ãå®æ°ã10åïŒé«ãïŒã§ãããšããããªãä¿¡ææ§ã®ããææãããæã£ãŠããŸããããŸãããã«ãã¯æ¬¡ã®æ§ã«èªãã
ã2016幎ã®ããŒããŒã倧åŠã®ããŒã¿ãããã¯ã¯ãã³æ害äºè±¡å ±åã·ã¹ãã ïŒVAERSïŒã¯ãå®éã«èµ·ãã£ãŠããããšã®10ïŒ çšåºŠããå ±åããŠããªãããšãããã£ãŠããŸããã
ã ãããå¥ã®ããŒã¿ãœãŒã¹ãæã«å ¥ããªããã°ãªããªãã£ãã®ã§ãã
ãããŠãç§ãã¡ã«ã¯VAERSã®å éšã®äººéãããŸãã
çŸåšãCMSã«ã¯å éšåçºè ããããCDCã«ã¯2人ã®å éšåçºè ãããŸãããããå ¬è¡šããããã«ãä»ãéçºãé²ããŠããŸãã
ã€ãŸãã10åã«ãªããšèããŠããŸããç§ãã¡ã¯5äžäººã®ã¢ã¡ãªã«äººãæ»ãã ãšèããŠããŸãã
50,000. ã€ãŸãã1æ¥ãããã®ã¯ã¯ãã³ã«ããæ»äº¡è æ°ã¯ããŠã€ã«ã¹æ§çŸæ£ã«ããæ»äº¡è æ°ãã¯ããã«äžåã£ãŠããã®ã§ããåºæ¬çã«ãããæå³ã§ã泚å°ã«ãããã€ãªããã®å®£äŒã§ãã
å é±ã®éææ¥ã«çºè¡šãããCDCã®VAERSã·ã¹ãã ã®ææ°ããŒã¿ã«ãããšã2020幎12æ14æ¥ãã2021幎6æ25æ¥ãŸã§ã®éã«ãå®éšçãªCOVID-19éºäŒåæ²»çã¯ã¯ãã³ã®æ³šå°åŸã«ã6,985人ã®æ»äº¡ãš34,065人ã®éå·ãå«ãåèš411,931件ã®æ害äºè±¡ãç±³åœå ã§å ±åãããŠããããšãæããã«ãªã£ãŠããŸãã
ãã«ãã®èšããšãããå®éã®æ»äº¡è æ°ãäžèšã®å ±åæžã®10åã§ããã°ãç±³åœã§ã®å®éã®æ»äº¡è æ°ã¯7äžäººã«è¿ã¥ããŠããããšã«ãªããŸãã
ãã¯ã¯ãã³ãäºæ¥ã¯ãã¹ãŠãäœçºçãã§ããããããäžåŠã®åå ãšãªãå¯èœæ§ããããŸãã
ãããµã¹å·ã®å»åž«ã¯ããã«ãã¯ãªãŒãã©ã³ãã»ã¯ãªããã¯ã®ããŒã¿ãä»ã®ç 究çµæãããããã§ã«å ç«ãæã£ãŠãã人ãèªç¶ã«å ç«ãæã£ãŠãã人ãã®30ïœ50ïŒ ãããŸã ã¯ã¯ãã³ãåããŠããããšãæããã«ããŸããã
ãã®ãããªäººãã¡ã«çç©åŠç補å€ã泚å°ããå»åŠçãèšåºçãå®å šäžã®çç±ã¯äœããªãã®ã§ãã¯ã¯ãã³ã¯äººå·¥çã«äœããããã®ãå šãŠãä»çµãŸããŠããäºãæããã§ãããã
ä»ãCDCã¯åšæã®éŸå€ãäœãå€æŽããã®ã§ãçäŸæ°ãæžãäºã«ãªããã¯ã¯ãã³ã§çäŸæ°ãæ»äº¡æ°ãæžã£ãããã«èŠããã®ã§ãã
ä»ã®ããŒã¿ãèŠãŠããã«ãã¯ãããã®æ°ããå®éšçãªéºäŒåæ²»çã®æ³šå°ããè¥å¹Žå±€ã®ãããäžåŠçãå©é·ããå¯èœæ§ãå±æ§ããŠããŸãããp53ãBRCAïŒä¹³ããéºäŒåïŒãšçžäºäœçšãããšãããæåã®æ³šå°ã§ããã£ãããšã«åºã¥ããŠãæçµçã«ããã«ã€ãªããã®ã§ã¯ãªãããšéåžžã«å¿é ããŠããŸããçã«ãªãå¯èœæ§ãããã®ã§ããã
ããã«ããæ¥æ¬äººã¯ãã§ã«ãè質ç²åãåµå·£ã«éäžããããšã瀺ããŠããŸãããšèª¬æããŠããŸããäžåŠçã«ãªãã®ã§ã¯ïŒ
âŒïžããããããã²ã€ã財å£ã®äººå£åæžããã°ã©ã ã ãšãããããã®ä»®èª¬ã«ãŽã£ããåœãŠã¯ãŸããŸããã第äžæ³¢ã¯ãåŒåžåšç³»ã®ææçã§è人ã殺ãããšã第2ã®æ³¢ã¯ãçãæ®ã£ãè¥è ãã¿ãŒã²ããã«ããŠãäžåŠæè¡ãããããšã§ããã
æ°ã¥ããŠã¿ããšãåœãã¢ã¡ãªã«ã§ã®ã¡ãã»ãŒãžã³ã°ã¯ãä»ã¯è人ã«ã¯èå³ããªããåäŸãã¿ãŒã²ããã§ããåäŸãã¡ã«çŠç¹ãåœãŠãŠãããããšãã«ãã¯åŒ·èª¿ããŸãã
ðãã©ã¹ã¡ã³ããè
è¿«ãè¡ã£ã倧åŠã®çœª
ããã«ãCOVID-19ã®å®éšçãªæ¥çš®ãåŠçã«çŸ©åã¥ããŠããå€ãã®å€§åŠã¯ãèªå®æ©é¢ãå¿ èŠãšããããªã·ãŒãæžãããŠããªãç¶æ ã§ãããè¡ãããšããŠããŸãã
ãæ²»éšçšã¯ã¯ãã³ã®æ¥çš®ã矩åä»ããæ¹éãæžãããšã¯ã§ããªãããšãç¥ã£ãŠããã®ã§ã眲åãããæ¹éã¯ãããŸããããç 究ã«åå ããããšã匷å¶ãããããªæ¹éã¯ããããŸããã
ã§ããããããããæ©é¢ãç é¢ã倧åŠãããªã·ãŒãªãã«ã¯ã¯ãã³ãèŠæ±ããããããã¯å®çŸ©äžããã©ã¹ã¡ã³ããè è¿«ã«ãªããŸããããšãã«ãã¯èª¬æããŠããŸãã
ãã®å»åŠææã¯ããã¥ãŒã¹ãã³ã»ã¡ãœãžã¹ãç é¢ãéçšæ¡ä»¶ãšããŠãå®éšçãªCOVID-19ã¯ã¯ãã³ã®æ¥çš®ãæ¢åã®åŸæ¥å¡ããã³æ°èŠæ¡çšè ã«çŸ©åä»ããããšããŠããããšãçç±ã«ããã¥ãŒã¹ãã³ã»ã¡ãœãžã¹ãç é¢ãçžæåã£ãŠäºãããŠãããã«ãŠã§ã¶ãŒèšŽèšã®äž»ä»»å°é家ã§ãã
ðããŒã ã®åªåãçãã æ°ã
ã®åå©
ã€ã³ã¿ãã¥ãŒã®äžã§ã埪ç°åšå ç§å»ã¯ãã¢ã¡ãªã«å ç§å»å€ç§å»åäŒãšååããŠåšå® æ£è ã¬ã€ããäœæããããšããã¢ã¡ãªã«ã4ã€ã®é éå»çãµãŒãã¹ã«åããããšãªã©ãèªåãã¡ãåã¡åã£ãå€ãã®ææã玹ä»ããŸããã
ãæ¿åºã®ç解ãåŸãããªããŸãŸã12ææ«ãã1æã«ãããŠãã¢ã¡ãªã«ã§ã®æµè¡æ²ç·ã厩ããŸãããåºæ¬çã«ã¯ãçŽ50人ã®å»åž«ãšé éå»çãµãŒãã¹ã§ãã³ãããã¯ã«å¯ŸåŠããŸããããããŠä»æ¥ã«è³ããŸã§ãç±³åœã®COVID-19éå£ã®ãã¡ãå®éã«ãã€ãªã¹ã¯ã§ãã50æ³ä»¥äžã®å»åŠçåé¡ãæ±ãã人ãé節ãªçç¶ãåãã人ã®çŽ25ïŒ ãæ²»çããŠããŸããã
圌ããå®éšçã«è¡ã£ãCOVID-19ã¯ã¯ãã³ã®åè掻åã¯ã4æ8æ¥ä»¥éã®ç¶ç¶çãªæ¥çš®çã®äœäžããããããæ¿åºã®æšé²è ã¯ãå人ã«ã¯ã¯ãã³ãæ¥çš®ãããã説åŸããããšã«å¿ æ»ã«ãªã£ãŠãããã
ãç§ã¯ãããµã¹å·ã«äœãã§ããŸãããããã§ã¯ããã¯ããŠã³ã¯è¡ãããŸããã§ãããç§ã¯å¶æ¥ãç¶ããããšã匷ãæ¯æããŠããŸããããããµã¹å·ã§ã¯ãããã¯ããŠã³ã¯ãããŸããã§ãããç¥äºã説åŸããŠãèªç¶å ç«ãèªããå ¬çæ©é¢ã«ããã¯ã¯ãã³æ¥çš®ã®çŸ©ååãçŠæ¢ããã¯ã¯ãã³ãã¹ããŒããçŠæ¢ãããã¹ããŒãã§ã®å·®å¥ãçŠæ¢ãã倧統é 什ãåºãããšãã§ããŸãããããšèª¬æããŠããŸãã
ã¯ã·ã³ãã³ã®ãã³ã»ãžã§ã³ãœã³ïŒR-WIïŒãšã©ã³ãã»ããŒã«ïŒR-KYïŒãå³æ¹ã«ã€ãããã©ãã¯ã¹ã»ãã¥ãŒã¹ããªã¢ã«ã»ãã¥ãŒã¹ãOANãªã©ã®ã¡ãã£ã¢ãå©çšããŠã圌ãã®ããããã«çµæãããC-19ã°ã«ãŒãã¯ãçŸåšãç±³åœã§ã¯ã»ãŒæ¯æ©ãå šåœãããã®ãã¬ãã«åºæŒããCDCãšNIHã®ã¢ã³ãœããŒã»ãã¡ãŠããšã¯ã¬ã³ã¹ããŒã«åè«ããŠããŸãã